Given approval - Its an easy prescription to make, from irbesartan TO DMX-200 which is irbesartan and propagermanium. From the physicians perspective atleast some upside to excellent results could be expected with little downside risk relative to other meds (ie blood pressure drugs), which is a great advantage Dimerix have. Certainly a drug worth trying for those already on irbesartan, no-brainer really one would expect.
Ann: Shareholder Briefing, page-101
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.005(1.25%) |
Mkt cap ! $223.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $758.5K | 1.897M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20986 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 110235 | 2 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |